Effects of Whole Egg Consumption on Inflammation, Mood, and Recovery in Collegiate Female Gymnasts

Sponsor
Iowa State University (Other)
Overall Status
Completed
CT.gov ID
NCT05034315
Collaborator
(none)
13
1
2
22
0.6

Study Details

Study Description

Brief Summary

The objectives were to investigate the effects of whole egg consumption by collegiate female gymnasts on inflammatory markers, mood, and recovery.

Condition or Disease Intervention/Treatment Phase
  • Other: Whole egg consumption
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
13 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Effects of Whole Egg Consumption on Inflammation, Mood, and Recovery in Collegiate Female Gymnasts
Actual Study Start Date :
Jul 1, 2018
Actual Primary Completion Date :
Apr 30, 2019
Actual Study Completion Date :
Apr 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Whole egg consumption

Other: Whole egg consumption
The participants in the whole egg group consumed two whole eggs immediately after exercise.

No Intervention: No egg control

Outcome Measures

Primary Outcome Measures

  1. Serum C-reactive protein (CRP) [8 months]

  2. Serum interleukin-6 (IL-6) [8 months]

  3. Serum soluble interleukin-6 receptor (sIL-6R) [8 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 22 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Membership on the university gymnastics team
Exclusion Criteria:
  • egg allergies, asthma, coronary artery disease, depression, diabetes, hypertension, migraines, cancer or cancer-related complications, or auto-immune disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Iowa State University Ames Iowa United States 50011

Sponsors and Collaborators

  • Iowa State University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Iowa State University
ClinicalTrials.gov Identifier:
NCT05034315
Other Study ID Numbers:
  • 17-309
First Posted:
Sep 5, 2021
Last Update Posted:
Sep 5, 2021
Last Verified:
Sep 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 5, 2021